A 5mg vial reconstituted with 2ml yields 2.5mg/ml
Injectable anti-aging protocol: Dose: 1-2mg daily Frequency: 5 days on, 2 days off OR daily for 30 days Cycle: 30 days on, 14 days off Duration: Minimum 2-3 cycles for substantial results Topical anti-aging protocol: Concentration: 2-3% serum or cream Application: Twice daily (morning and evening) Duration: 12+ weeks continuous use Combine with: Sunscreen (always), retinoids (evening, separate application) Combination approach: Maximum anti-aging results come from combining injectable and topical
Common sites are the abdomen or thigh
Research on neurotransmitter-system interactions has also been compiled in recent reviews, broadening the picture beyond the classical angiogenic and gastric framings (PMID 38675421)
Retatrutide, in early data, outperforms tirzepatide suggesting incremental receptor targeting translates to incremental efficacy
The FDAs Pharmaceutical Compounding Advisory Committee (PCAC) voted to add six of seven peptides to the 503A Bulk Drug Substance List, despite FDA scientists recommending against all of them because of limited evidence of their safety and effectiveness